Ratios Financieros

1. Kondo, K. Rising prevalence of neurodegenerative diseases worldwide. Intern. Med.35, 238 (1996).

2. Mayeux, R. Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 26, 81–104 (2003).

3. George, M., Norris, M., Nault, F., Loh, S. & Dai, S. Population Projections for Canada, Provinces and Territories 2009-2036. 1–248 (2009). at <http://www.popline.org/node/290587>

4. CNIB Report. The Cost of Vision Loss in Canada. 1–26 (2009). at

<http://www.cnib.ca/eng/CNIB Document

Library/Research/Summaryreport_Covl.pdf>

5. Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N. Engl. J. Med.358, 2606–17 (2008).

6. Wang, L. et al. Abundant lipid and protein components of drusen. PLoS One 5,

e10329 (2010).

7. Kolb, H. How the retina works. Am. Sci.91, 27–35 (2003).

8. Antonetti, D. A., Klein, R. & Gardner, T. W. Diabetic retinopathy. N. Engl. J. Med.366, 1227–39 (2012).

9. Kwon, Y. H., Fingert, J. H., Kuehn, M. H. & Alward, W. L. M. Primary open- angle glaucoma. N. Engl. J. Med.360, 1113–24 (2009).

10. Alward, W. L. M. Medical management of glaucoma. N. Engl. J. Med. 339, 1298– 1307 (1998).

11. Smith, R., Joh, S., Nishina, P. & Sandberg, J. Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods. 20012478, 1–384 (CRC Press, 2001). 12. Dowling, J. E. Organization of vertebrate retinas. Invest. Ophthalmol. 9, 655–80

(1970).

13. Thompson, D. A. & Gal, A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog. Retin. Eye Res. 22, 683–703 (2003).

14. Baylor, D. How photons start vision. Proc. Natl. Acad. Sci. U. S. A. 93, 560–5 (1996).

15. Strauss, O. The retinal pigment epithelium in visual function. Physiol. Rev. 85,

845–881 (2005).

16. Kolb, H. Photoreceptors. Webvision Organ. Retin. Vis. Syst. (2014). at <http://webvision.med.utah.edu/book/part-ii-anatomy-and-physiology-of-the- retina/photoreceptors/>

17. Müller, B. & Peichl, L. Horizontal cells in the cone-dominated tree shrew retina: morphology, photoreceptor contacts, and topographical distribution. J. Neurosci. Off. J. Soc. Neurosci.13, 3628–46 (1993).

18. Masland, R. H. The neuronal organization of the retina. Neuron 76, 266–80 (2012).

19. MacPherson, T. C. Ocular phenotyping in the harlequin mouse model of retinal degeneration: a framework for therapeutic testing. 1–265 (2009).

20. Arshavsky, V. Y., Lamb, T. D. & Pugh, E. N. G proteins and phototransduction. Annu. Rev. Physiol.64, 153–87 (2002).

21. Koutalos, Y. & Ebrey, T. Recent progress in vertebrate photoreception. Photochem. Photobiol.44, 809–817 (1986).

22. Fu, Y. Phototransduction in rods and cones. Webvision Organ. Retin. Vis. Syst. (2014). at <http://webvision.med.utah.edu/book/part-v-phototransduction-in-rods- and-cones/phototransduction-in-rods-and-cones/>

23. Wang, T. & Montell, C. Phototransduction and retinal degeneration in Drosophila. Pflügers Arch. Eur. J. Physiol.454, 821–47 (2007).

24. Wu, J., Seregard, S. & Algvere, P. V. Photochemical damage of the retina. Surv. Ophthalmol.51, 461–81 (2006).

25. Kolb, H. Glial cells of the retina. Webvision Organ. Retin. Vis. Syst. (2014). at <http://webvision.med.utah.edu/book/part-ii-anatomy-and-physiology-of-the- retina/glial-cells-of-the-retina/>

26. Tsacopoulos, M. & Magistretti, P. Metabolic coupling glia and neurons. J. Neurosci.76, 877–885 (1996).

27. Matsui, K., Hosoi, N. & Tachibana, M. Active role of glutamate uptake in the synaptic transmission from retinal nonspiking neurons. J. Neurosci. 19, 6755–66 (1999).

28. Long, K. O., Fisher, S. K., Fariss, R. N. & Anderson, D. H. Disc shedding and autophagy in the cone-dominant ground squirrel retina. Exp. Eye Res.43, 193–205 (1986).

29. Tout, S., Chan-ling, T., Hollander, H. & Stone, J. The role of Muller cells in the formation of the blood-retina barrier. Neuroscience55, 291–301 (1993).

30. Reichenbach, A., Henke, A., Eberhardt, W., Reichelt, W. & Dettmer, D. K+ ion regulation in the retina. Can. J. Physiol. Pharmacol.70, 239–47 (1992).

31. Biissow, H. The astrocytes in the retina and optic nerve head of mammals: a special glia for the ganglion cell axons. Cell Tissue Res.206, 367–378 (1980). 32. Stone, J. & Dreher, Z. Relationship between astrocytes, ganglion cells and

vasculature of the retina. J. Comp. Neurol.255, 35–49 (1987).

33. Gardner, T. W. et al. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci.38, 2423–7 (1997). 34. Tao-Cheng, J. H., Nagy, Z. & Brightman, M. W. Tight junctions of brain

endothelium in vitro are enhanced by astroglia. J. Neurosci.7, 3293–3299 (1987). 35. Hanisch, U. Microglia as a source and target of cytokines. Glia40, 140–55 (2002). 36. Streit, W. J. Microglia as neuroprotective, immunocompetent cells of the CNS.

Glia40, 133–9 (2002).

37. Graeber, M. B. & Streit, W. J. Microglia: biology and pathology. Acta Neuropathol.119, 89–105 (2010).

38. Kono, H. & Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol.8, 279–289 (2008).

39. Stahl, W. L. The Na, K-ATPase of nervous tissue. Neurochem. Int. 8, 449–476 (1986).

40. Wong-Riley, M. Energy metabolism of the visual system. Eye Brain 2, 99–116 (2010).

41. Vilchez, D. et al. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat. Neurosci.10, 1407–13 (2007). 42. Brown, A. M. Brain glycogen re-awakened. J. Neurochem.89, 537–52 (2004). 43. Rapoport, S. I. Functional brain imaging in the resting state and during activation

44. Bélanger, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab.14, 724–38 (2011).

45. Herrero-Mendez, A. et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell Biol.11, 747–52 (2009).

46. Runkle, E. A. & Antonetti, D. A. in Blood-Brain Other Neural Barriers Rev. Protoc. Methods Mol. Biol.686, 133–148 (2011).

47. Hori, S., Ohtsuki, S., Hosoya, K., Nakashima, E. & Terasaki, T. A pericyte- derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J. Neurochem.

89, 503–13 (2004).

48. Kniesel, U. & Wolburg, H. Tight junction complexity in the retinal pigment epithelium of the chicken during development. Neurosci. Lett.149, 71–4 (1993). 49. Austin, B. A., Liu, B., Li, Z. & Nussenblatt, R. B. Biologically active fibronectin

fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci.50, 2896–2902 (2010).

50. Caldwell, R. B. et al. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes. Metab. Res. Rev.19, 442–55 (2003).

51. Cunha-Vaz, J., Faria de Abreu, J. R. & Campos, a J. Early breakdown of the blood-retinal barrier in diabetes. Br. J. Ophthalmol.59, 649–56 (1975).

52. Penn, R. & Hagins, W. Signal transmission along retinal rods and the origin of the electroretinographic a-wave. Nature223, 201–205 (1969).

53. Müller, R. & Dowling, J. Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram. J. Neurophysiol.33, 323–41 (1970).

54. Wachtmeister, L. Oscillatory potentials in the retina: what do they reveal. Prog. Retin. Eye Res.17, 485–521 (1998).

55. Heynen, H., Wachtmeister, L. & Vvan Norren, D. Origin of the oscillatory potentials in the primate retina. Vision Res.25, 1365–1373 (1985).

56. Dong, C.-J., Agey, P. & Hare, W. A. Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis. Neurosci.21, 533–43 (2004).

57. Granit, R. Two types of retinae and their electrical responses to intermittent stimuli in light and dark adaptation. J. Physiol.85, 421–438 (1935).

58. Jeon, C. J., Strettoi, E. & Masland, R. H. The major cell populations of the mouse retina. J. Neurosci.18, 8936–46 (1998).

59. Cotlier, E., Weinreb, R., Tzekov, R. & Arden, G. B. The electroretinogram in diabetic retinopathy. Surv. Ophthalmol.44, 53–60 (1999).

60. Lachapelle, P., Benoit, J., Little, J. M. & Faubert, J. The diagnostic use of the second oscillatory potential in clinical electroretinography. Doc. Ophthalmol. 73,

327–36 (1989).

61. Bui, B. V, Edmunds, B., Cioffi, G. A. & Fortune, B. The gradient of retinal functional changes during acute intraocular pressure elevation. Invest. Ophthalmol. Vis. Sci.46, 202–13 (2005).

62. Li, Q., Zemel, E., Miller, B. & Perlman, I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp. Eye Res.74,

615–25 (2002).

63. Hancock, H. A. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest. Ophthalmol. Vis. Sci.45, 1002–1008 (2004).

64. Hara, A. & Miura, M. Decreased inner retinal activity in branch retinal vein occlusion. Doc. Ophthalmol.88, 39–47 (1994).

65. Yonemura, D., Aoki, T. & Tsuzuki, K. Electroretinogram in diabetic retinopathy. Arch. Ophthalmol.68, 19–24 (1962).

66. Akula, J. D., Mocko, J. A., Moskowitz, A., Hansen, R. M. & Fulton, A. B. The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci.48, 5788–97 (2007).

67. Marmor, M. F. et al. ISCEV standard for full-field clinical electroretinography (2008 update). Doc. Ophthalmol.118, 69–77 (2009).

68. Meklenburg, J., Clancy, E. A. & Tzekov, R. Signal processing techniques for oscillatory potential extraction in the electroretinogram: automated highpass cutoff frequency estimation. Doc. Ophthalmol.125, 101–11 (2012).

69. Zhang, K., Yao, G., Gao, Y., Hofeldt, K. J. & Lei, B. Frequency spectrum and amplitude analysis of dark- and light-adapted oscillatory potentials in albino mouse, rat and rabbit. Doc. Ophthalmol.115, 85–93 (2007).

70. Lei, B., Yao, G., Zhang, K., Hofeldt, K. J. & Chang, B. Study of rod- and cone- driven oscillatory potentials in mice. Invest. Ophthalmol. Vis. Sci. 47, 2732–8 (2006).

71. Hood, D. C. & Birch, D. G. Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest. Ophthalmol. Vis. Sci.35, 2948–61 (1994).

72. Granit, R. The componenets of the retinal action potential in mammals and their relation to the discharge in the optic nerve. J physiol77, 207–239 (1933).

73. Lamb, T. D. & Pugh, E. N. A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J. Physiol. 449, 719–758 (1992).

74. Hood, D. C. & Birch, D. G. Phototransduction in human cones measured using the alpha-wave of the ERG. Vision Res.35, 2801–10 (1995).

75. Bui, B. V., Armitage, J. A. & Vingrys, A. J. Extraction and modelling of oscillatory potentials. Doc. Ophthalmol.104, 17–36 (2002).

76. Li, X. X. & Yuan, N. Measurement of the oscillatory potentials of the electroretinogram in the domains of frequency and time. Doc. Ophthalmol.76, 65– 71 (1990).

77. Moskowitz, A., Hansen, R. M. & Fulton, A. B. ERG oscillatory potentials in infants. Doc. Ophthalmol.110, 265–70 (2005).

78. Liu, K. et al. Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest. Ophthalmol. Vis. Sci.47, 5447–52 (2006).

79. Mactier, H., Bradnam, M. S. & Hamilton, R. Dark-adapted oscillatory potentials in preterm infants with and without retinopathy of prematurity. Doc. Ophthalmol.

127, 33–40 (2013).

80. Vallabhan, G., Kristiansen, S., Price, J. & Young, R. S. Effect of adaptation and wavelength on the power spectrum of human oscillatory potentials. Doc. Ophthalmol.69, 145–51 (1988).

81. Van der Torren, K., Groeneweg, G. & van Lith, G. Measuring oscillatory potentials: fourier analysis. Doc. Ophthalmol.69, 153–9 (1988).

82. Everitt, B. & Hothorn, T. An Introduction to Applied Multivariate Analysis with R. 1–273 (Springer Science, 2011).

83. Kruskal, J. B. Multidimensional scaling by optimizing goodness of fit to a nonmetric hypothesis. Psychometrika29, 1–27 (1964).

84. Shepard, R. The analysis of proximities: multidimensional scaling with an unknown distance function. Psychometrika27, 125–140 (1962).

85. Holland, S. M. Non-metric multidimensional scaling (MDS). 1–7 (2008). at <http://strata.uga.edu/6370/lecturenotes/multidimensionalScaling.html>

86. Jarrett, S. G., Lin, H., Godley, B. F. & Boulton, M. E. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog. Retin. Eye Res. 27, 596–607 (2008).

87. Niven, J. E. & Laughlin, S. B. Energy limitation as a selective pressure on the evolution of sensory systems. J. Exp. Biol.211, 1792–1804 (2008).

88. Anderson, B. & Saltzman, H. Retinal oxygen utilization measured by hyperbaric blackout. Arch. Ophthalmol.72, 792–795 (1964).

89. Yu, D. Y. & Cringle, S. J. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog. Retin. Eye Res.20, 175–208 (2001).

90. Barot, M., Gokulgandhi, M. R. & Mitra, A. K. Mitochondrial dysfunction in retinal diseases. Curr. Eye Res.36, 1069–77 (2011).

91. Chung, S., Lee, A. & Chung, S. Mouse models for human diseases. Hong Kong Med. J.3, 201–209 (1997).

92. Tsonis, P. Animal Models in Eye Research. 1–215 (Elsevier Ltd, 2008).

93. Klein, J. A. et al. The harlequin mouse mutation down-regulates apoptosis- inducing factor. Nature419, 367–374 (2002).

94. Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature397, 441–6 (1999).

95. Bénit, P., Goncalves, S., Dassa, E. P., Brière, J. J. & Rustin, P. The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I- deficiency syndromes. PLoS One3, e3208 (2008).

96. Brown, D. et al. Loss of Aif function causes cell death in the mouse embryo, but the temporal progression of patterning is normal. Proc. Natl. Acad. Sci. U. S. A.

97. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature410, 549–54 (2001).

98. Vahsen, N. et al. AIF deficiency compromises oxidative phosphorylation. EMBO J.23, 4679–89 (2004).

99. Maté, M. J. et al. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat. Struct. Biol.9, 442–6 (2002).

100. Modjtahedi, N., Giordanetto, F., Madeo, F. & Kroemer, G. Apoptosis-inducing factor: vital and lethal. Trends Cell Biol.16, 264–72 (2006).

101. Chinta, S. J. et al. Reactive oxygen species regulation by AIF- and complex I- depleted brain mitochondria. Free Radic. Biol. Med.46, 939–947 (2010).

102. Laliberté, A. M., MacPherson, T. C., Micks, T., Yan, A. & Hill, K. A. Vision deficits precede structural losses in a mouse model of mitochondrial dysfunction and progressive retinal degeneration. Exp. Eye Res.93, 833–41 (2011).

103. Laliberte, A. M. DNA-damage-independent mitochrondrial dysfunction drives a loss of retina function prior to neuron death in the harlequin model of aging. Biol. London Univ. West. Ontario 1–145 (2010).

104. Mayers, J. Microglial activation in the harlequin mouse retina as a mechanism for early retinal degeneration. 1–132 (2012).

105. Prtenjaca, A. Cerebellar degeneration in harlequin mice is associated with inflammation unaltered by a phenobarbital hormetic treatment. Biol. London Univ. West. Ontario 1–258 (2012).

106. Riemer, J. & Kins, S. Axonal transport and mitochondrial dysfunction in Alzheimer’s disease. Neurodegener. Disord.12, 111–124 (2013).

107. Perier, C. & Vila, M. Mitochondrial biology and Parkinson’s disease. Cold Spring Harb. Perspect. Med.2, a009332 (2012).

108. Leoni, V. & Caccia, C. Study of cholesterol metabolism in Huntington’s disease. Biochem. Biophys. Res. Commun.446, 697–701 (2014).

109. Faes, L. & Callewaert, G. Mitochondrial dysfunction in familial amyotrophic lateral sclerosis. J. Bioenerg. Biomembr.43, 587–92 (2011).

110. Chen, H. & Chan, D. C. Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum. Mol. Genet.18, R169–76 (2009).

111. Verstreken, P. et al. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron47, 365–78 (2005). 112. Du, H. et al. Early deficits in synaptic mitochondria in an Alzheimer’s disease

mouse model. Proc. Natl. Acad. Sci.107, 18670–18675 (2014).

113. Gunter, T. E., Buntinas, L., Sparagna, G., Eliseev, R. & Gunter, K. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium28, 285–96 (2000). 114. Mbaya, E. et al. Calcium signalling-dependent mitochondrial dysfunction and

bioenergetics regulation in respiratory chain complex II deficiency. Cell Death Differ.17, 1855–66 (2010).

115. Simpson, P. B. & Russell, J. T. Role of mitochondrial Ca2+ regulation in neuronal and glial cell signalling. Brain Res. Brain Res. Rev.26, 72–81 (1998).

116. Ichas, F. & Mazat, J. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high- conductance state. Biochim. Biophys. Acta11366, 33–50 (1998).

117. Joza, N. et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol. Cell. Biol.25, 10261–10272 (2005).

118. Pospisilik, J. A. et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell131, 476–91 (2007). 119. Almeida, A., Almeida, J., Bolaños, J. P. & Moncada, S. Different responses of

astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc. Natl. Acad. Sci. U. S. A.98, 15294–9 (2001).

120. Schapira, A. H. V, Cooper, T. S. J. M., Clark, J. B., Jenner, P. & Marsden, T. C. D. Mitochondrial complex I deficiency in Parkinson’s disease. J. Neurochem. 54,

823–827 (1990).

121. Xu, H., Chen, M. & Forrester, J. V. Para-inflammation in the aging retina. Prog. Retin. Eye Res.28, 348–368 (2009).

122. Medzhitov, R. & Janeway, C. The toll receptor family and microbial recognition. Trends Microbiol.8, 452–6 (2000).

123. Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol.81, 1–5 (2007).

124. Medzhitov, R. & Janeway, C. A. Decoding the patterns of self and nonself by the innate immune system. Science (80-. ).296, 298–300 (2002).

125. Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature418, 191–5 (2002).

126. Herold, K. et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J. Leukoc. Biol.82, 204–12 (2007).

127. Spiteller, G. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic. Biol. Med.41, 362–87 (2006).

128. Stamatovic, S. M., Keep, R. F., Kunkel, S. L. & Andjelkovic, A. V. Potential role of MCP-1 in endothelial cell tight junction “opening”: signaling via Rho and Rho kinase. J. Cell Sci.116, 4615–28 (2003).

129. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science308, 1314–8 (2005). 130. Haynes, S. E. et al. The P2Y12 receptor regulates microglial activation by

extracellular nucleotides. Nat. Neurosci.9, 1512–9 (2006).

131. Langmann, T. Microglia activation in retinal degeneration. J. Leukoc. Biol. 81,

1345–51 (2007).

132. MacPherson, T. Ocular phenotyping in the harlequin mouse model of retinal degeneration: A framework for therapeutic testing. Biol. London Univ. West. Ontario 271 (2009).

133. Ibbotson, C. Assessment of retinal dysfunction in memantine-treated and untreated harlequin and wild-type mice using five parameters of the electroretinogram. 1–42 (2012).

134. Xu, Q., Qaum, T. & Adamis, A. P. Sensitive blood – retinal barrier breakdown quantitation using Evans blue. Invest. Ophthalmol. Vis. Sci.42, 789–794 (2001). 135. Chen, K. B. et al. Increase in Evans blue dye extravasation into the brain in the late

developmental stage. Neuroreport23, 699–701 (2012).

136. Radu, M. & Chernoff, J. An in vivo assay to test blood vessel permeability. J Vis Exp73, e50062 (2013).

137. Matragoon, S. & Liou, G. RNA extraction from single mouse retinas by sand homogenizatoin and the RNeasy Mini procedure. Qiagen News5, 10–11 (1996).

138. Suzuki, T., Higgins, P. & Crawford, D. Control selection for RNA quantitation. Biotechniques29, 332–337 (2000).

139. Bustin, S. A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25, 169–93 (2000).

140. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25,

402–408 (2001).

141. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res.37, 1–13 (2009).

142. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4,

44–57 (2009).

143. Cunningham, S. et al. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest. Ophthalmol. Vis. Sci. 41, 4275–80 (2000).

144. Hong, H. et al. Neonatal systemic inflammation in rats alters retinal vessel development and simulates pathologic features of retinopathy of prematurity. J. Neuroinflammation11, 87 (2014).

145. Gao, H. & Hollyfield, J. G. Aging of the human retina. Invest. Ophthalmol. Vis. Sci.33, 1–17 (1992).

146. Kergoat, H., Kergoat, M. J. & Justino, L. Age-related changes in the flash electroretinogram and oscillatory potentials in individuals age 75 and older. J. Am. Geriatr. Soc.49, 1212–7 (2001).

147. Kolesnikov, A. V, Fan, J., Crouch, R. K. & Kefalov, V. J. Age-related deterioration of rod vision in mice. J. Neurosci.30, 11222–31 (2010).

148. Dai, D.-F., Rabinovitch, P. S. & Ungvari, Z. Mitochondria and cardiovascular aging. Circ. Res.110, 1109–24 (2012).

149. Abbott, N. J., Rönnbäck, L. & Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci.7, 41–53 (2006).

In document La Gestión financiera y la rentabilidad de la empresa de servicios turisticos "Hostería Arrayan y Piedra" de la ciudad de Macas – Ecuador periodo 2015 – 2018 (página 69-73)